Currently most of the ECPs used commercially for mechanical ventilation involve both open and closed-loop ventilation rules.
In addition, about 85% of the cases of hospital-acquired sinusitis associated with mechanical ventilation involve the maxillary sinuses [ 6].
The use of surfactant seems to indicate that the newborn had to be intubated and receive mechanical ventilation, involving a complexity of care that existing structures in the evaluated maternity units were not able to offer.
Animal studies [ 17, 18] have shown that mechanical ventilation involving the application of high airway pressures or large tidal volumes (VTs) in combination with too high or too low PEEP may generate shear forces that effect healthy or diseased lungs, and can increase capillary permeability, promote gas leaks and oedema, and initiate inflammation.
VILI is now considered as one of the most serious complications of mechanical ventilation and involves several mechanisms [ 5], namely: alveolar over-distension (volutrauma), atelectrauma, barotrauma and inflammatory reactions (biotrauma).
Mechanical ventilation (MV), involving the use of mechanical force to offload respiratory muscles of their work, is a fundamental component of treatment in the intensive care unit (ICU) for patients with ARDS.
No supplemental oxygen, fluids, or mechanical ventilation were involved during the anesthesia period.
Recent work in animal VILI models revealed that a large number of genes in the lung were markedly upregulated by mechanical ventilation, including genes involved in immunity and inflammation (MIP1, MIP2, IL-1β, and IL-6), stress response (GADD45-γ), and transcription processes (IRF-7, ATF-3) [ 5].
All cases involved withdrawal of invasive mechanical ventilation and some also involved cessation of inotropic circulatory support.
Treatment of patients with acute respiratory failure (ARF) involves mechanical ventilation via endotracheal intubation (INV).
